These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10146556)

  • 21. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the validity of the INR system for patients with liver impairment.
    Kovacs MJ; Wong A; MacKinnon K; Weir K; Keeney M; Boyle E; Cruickshank M
    Thromb Haemost; 1994 Jun; 71(6):727-30. PubMed ID: 7605424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of seven prothrombin time reagents--development of an evaluation strategy.
    Carter CJ; Griswold DJ; Louis RA; Hershler R; Wadsworth LD
    Mod Pathol; 1988 Jul; 1(4):284-7. PubMed ID: 3237706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
    Kitchen S; Preston FE
    Thromb Haemost; 1996 May; 75(5):734-9. PubMed ID: 8725715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?
    Keshgegian AA; Mann JM; Cooper JH
    Arch Pathol Lab Med; 1986 Jun; 110(6):520-2. PubMed ID: 3754725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time.
    Roussi J; Drouet L; Samama M; Sié P
    Thromb Haemost; 1994 Nov; 72(5):698-704. PubMed ID: 7900077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of PT, aPTT, and factor VII values obtained by concurrent sample collection by direct venipuncture and peripheral venous catheters.
    Lindley C; Sawyer W; Haddon T; Meade J; Nolen J; Johansen L; Roberts H
    Pharmacotherapy; 1994; 14(2):224-8. PubMed ID: 8197044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
    Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
    Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
    Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
    Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring of coagulation status in the physician's laboratory].
    Marbet GA
    Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of PT and aPTT values drawn by venipuncture and arterial line using three discard volumes.
    Konopad E; Grace M; Johnston R; Noseworthy T; Shustack A
    Am J Crit Care; 1992 Nov; 1(3):94-101. PubMed ID: 1307912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laboratory control over warfarin therapy in patients with acute coronary syndrome].
    Baluda MV; Lopukhina MV; Fomina VM; Lopukhin VO
    Ter Arkh; 2005; 77(10):68-71. PubMed ID: 16320690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
    Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
    Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.